Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
13.82
+0.10 (0.73%)
At close: Sep 17, 2026, 4:00 PM EDT
13.57
-0.25 (-1.83%)
After-hours: Sep 17, 2026, 7:30 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $411.67 million as of September 17, 2026.
Market Cap
411.67M
Enterprise Value
407.50M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.82
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $411.67M, an increase of 109.86%. That is a compound annual growth rate of 119.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 411.67M | 254.85% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 421.98M |
| Editas Medicine | 420.81M |
| Indaptus Therapeutics | 418.38M |
| Benitec Biopharma | 415.00M |
| BridgeBio Oncology Therapeutics | 404.88M |
| Larimar Therapeutics | 394.57M |
| vTv Therapeutics | 390.64M |
| Galectin Therapeutics | 387.26M |